跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
INHIXA Solution for Injection 6000 Anti-Xa IU (60MG)/0.6ML - HSA Drug Approval Details
Approvals
/
HSA
/
INHIXA Solution for Injection 6000 Anti-Xa IU (60MG)/0.6ML
Approved
THERAPEUTIC
INHIXA Solution for Injection 6000 Anti-Xa IU (60MG)/0.6ML
Shenzhen Techdow Pharmaceutical Co., Ltd.
🇸🇬 Health Sciences Authority
Approval Date
May 7, 2024
Approval ID
d4ab6b63e600c590
Company
Shenzhen Techdow Pharmaceutical Co., Ltd.
Type
Therapeutic
Approval Details
Approval Id
d4ab6b63e600c590
Drug Name
INHIXA Solution for Injection 6000 Anti-Xa IU (60MG)/0.6ML
Product Name
INHIXA Solution for Injection 6000 Anti-Xa IU (60MG)/0.6ML
Approval Number
SIN16997P
Approval Date
2024-05-07
Registrant
PHARMAZEN MEDICALS PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, SOLUTION
Route Of Administration
SUBCUTANEOUS, INTRAVENOUS BOLUS
Atc Code
B01AB05
Pharma Manufacturer Name
PHARMAZEN MEDICALS PTE LTD
Company Detail Path
/organization/pharmazen-medicals-pte-ltd
Active Ingredients
Enoxaparin Sodium
6000 IU (60 MG)/0.6 ML
Enoxaparin Sodium
6000 IU (60 MG)/0.6 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 7, 2024
Approval ID
d4ab6b63e600c590
Type
Therapeutic
Back to HSA Approvals
